Target intelligence / Profile preview

Glycine-N-acyltransferase like 1B (GLYATL1B)

Target
GLYATL1B
Molecular classification
Enzyme (acyltransferase; specifically predicted as glutamine N-acyltransferase)
01

Overview

GLYATL1B encodes a putative acyltransferase, predicted to transfer an acyl group to the N-terminus of glutamine using phenylacetyl-CoA as an acyl donor[3]. It is related to the glycine N-acyltransferase gene family, but has scant direct evidence regarding its biological activity, clinical relevance, or disease association outside of database annotations. Its Ensembl ID is ENSG00000255151, HGNC ID is 37865, and the NCBI Gene ID is 100287520[3]. Some sources refer to GLYATL1B as a pseudogene (GLYATL1P3)—indicating it may not encode an active protein, but this is not fully clarified. In summary, GLYATL1B is annotated as a member of the glycine N-acyltransferase family, predicted to participate in the glutamine metabolic process, and currently lacks strong experimental evidence for being an actionable therapeutic target or a validated disease biomarker[3].

Other names
Putative glycine N-acyltransferase-like protein 1BGLYATL1BGLYATL1P3Glycine-N-acyltransferase like 1 pseudogene 3
02

Biological functions

Glutamine metabolic process (predicted)Acyl group transfer (predicted)
03

Disease associations

Scarlet fever (GeneCards-database association only)Other (no strong evidence, limited to predicted associations)

Beyond the preview

Go deeper on Glycine-N-acyltransferase like 1B (GLYATL1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycine-N-acyltransferase like 1B (GLYATL1B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call